The biggest-ever clinical test of a medicine for patients suffering from pediatric cardiology discovered that an oral drug considerably enhanced exercise capability in adolescent patients suffering from congenital, severe single-ventricle heart defects. A research leader claims the physiologic advantages represent a landmark in the care of those who have gone through the Fontan process, a…